In conclusion, our data provide strong evidence that TNFR2 stimulation is effective in ameliorating Aβ deposition and AD-related cognitive impairments and in modulating the phagocytic activity of glial cells in the CNS. This evidence concerns the gene TNFRSF1B and Alzheimer disease.